Cargando…

The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives

PURPOSE: To compare health care experiences of patients with cancer or non-cancer diseases in their last year of life. METHODS: A cross-sectional post-bereavement survey was conducted using an adapted German version of the VOICES questionnaire (VOICES-LYOL-Cologne). Differences in the reported exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasdorf, Alina, Dust, Gloria, Hamacher, Stefanie, Schippel, Nicolas, Rietz, Christian, Voltz, Raymond, Strupp, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046331/
https://www.ncbi.nlm.nih.gov/pubmed/35190893
http://dx.doi.org/10.1007/s00520-022-06908-8
_version_ 1784695500360908800
author Kasdorf, Alina
Dust, Gloria
Hamacher, Stefanie
Schippel, Nicolas
Rietz, Christian
Voltz, Raymond
Strupp, Julia
author_facet Kasdorf, Alina
Dust, Gloria
Hamacher, Stefanie
Schippel, Nicolas
Rietz, Christian
Voltz, Raymond
Strupp, Julia
author_sort Kasdorf, Alina
collection PubMed
description PURPOSE: To compare health care experiences of patients with cancer or non-cancer diseases in their last year of life. METHODS: A cross-sectional post-bereavement survey was conducted using an adapted German version of the VOICES questionnaire (VOICES-LYOL-Cologne). Differences in the reported experiences were assessed using a two-sided Pearson’s chi-square test and Mann–Whitney U test. RESULTS: We collected data from 351 bereaved relatives. More than half of non-cancer patients were not informed that their disease could lead to death (p < 0.001). When this was communicated, in 46.7% of non-cancer and 64.5% of cancer patients, it was reported by the hospital doctor (p = 0.050). In all, 66.9% of non-cancer and 41.6% of cancer patients were not informed about death being imminent (p < 0.001). On average, non-cancer patients had significantly fewer transitions and hospital stays in their last year of life (p = 0.014; p = 0.008, respectively). Non-cancer patients were treated more often by general practitioners, and cancer patients were treated more often by specialists (p = 0.002; p = 0.002, respectively). A substantially lower proportion of non-cancer patients were treated by at least one member of or in the setting of general or specialized palliative care (p < 0.001). CONCLUSIONS: Non-cancer patients experience disadvantages in communication regarding their care and in access to specialized palliative care in their last year of life compared to cancer patients. Regarding the assessment of palliative care needs and the lack of communication of an incurable disease, non-cancer patients are underserved. An early identification of patients requiring palliative care is a major public health concern and should be addressed irrespective of diagnosis. TRIAL REGISTRATION: Prospectively registered by the German Clinical Trials Register (DRKS00011925, data of registration: 13.06.2017).
format Online
Article
Text
id pubmed-9046331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90463312022-05-07 The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives Kasdorf, Alina Dust, Gloria Hamacher, Stefanie Schippel, Nicolas Rietz, Christian Voltz, Raymond Strupp, Julia Support Care Cancer Original Article PURPOSE: To compare health care experiences of patients with cancer or non-cancer diseases in their last year of life. METHODS: A cross-sectional post-bereavement survey was conducted using an adapted German version of the VOICES questionnaire (VOICES-LYOL-Cologne). Differences in the reported experiences were assessed using a two-sided Pearson’s chi-square test and Mann–Whitney U test. RESULTS: We collected data from 351 bereaved relatives. More than half of non-cancer patients were not informed that their disease could lead to death (p < 0.001). When this was communicated, in 46.7% of non-cancer and 64.5% of cancer patients, it was reported by the hospital doctor (p = 0.050). In all, 66.9% of non-cancer and 41.6% of cancer patients were not informed about death being imminent (p < 0.001). On average, non-cancer patients had significantly fewer transitions and hospital stays in their last year of life (p = 0.014; p = 0.008, respectively). Non-cancer patients were treated more often by general practitioners, and cancer patients were treated more often by specialists (p = 0.002; p = 0.002, respectively). A substantially lower proportion of non-cancer patients were treated by at least one member of or in the setting of general or specialized palliative care (p < 0.001). CONCLUSIONS: Non-cancer patients experience disadvantages in communication regarding their care and in access to specialized palliative care in their last year of life compared to cancer patients. Regarding the assessment of palliative care needs and the lack of communication of an incurable disease, non-cancer patients are underserved. An early identification of patients requiring palliative care is a major public health concern and should be addressed irrespective of diagnosis. TRIAL REGISTRATION: Prospectively registered by the German Clinical Trials Register (DRKS00011925, data of registration: 13.06.2017). Springer Berlin Heidelberg 2022-02-21 2022 /pmc/articles/PMC9046331/ /pubmed/35190893 http://dx.doi.org/10.1007/s00520-022-06908-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Kasdorf, Alina
Dust, Gloria
Hamacher, Stefanie
Schippel, Nicolas
Rietz, Christian
Voltz, Raymond
Strupp, Julia
The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title_full The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title_fullStr The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title_full_unstemmed The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title_short The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
title_sort last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046331/
https://www.ncbi.nlm.nih.gov/pubmed/35190893
http://dx.doi.org/10.1007/s00520-022-06908-8
work_keys_str_mv AT kasdorfalina thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT dustgloria thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT hamacherstefanie thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT schippelnicolas thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT rietzchristian thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT voltzraymond thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT struppjulia thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT thelastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT kasdorfalina lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT dustgloria lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT hamacherstefanie lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT schippelnicolas lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT rietzchristian lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT voltzraymond lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT struppjulia lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives
AT lastyearoflifeforpatientsdyingfromcancervsnoncancercausesaretrospectivecrosssectionalsurveyofbereavedrelatives